HIV Receives a "One Two Knockout Punch".
HIV Receives a "One Two Knockout Punch".
复制标题
HIV 受到“一二击倒”。
DOI:
10.1016/j.ymthe.2017.02.001
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Bollard,CatherineM
中科院分区:
文献类型:
--
作者:
Cruz,ConradRussell;Bollard,CatherineM
T cell therapies have shown promise against viral infections and malignancies. Moreover, advances in gene-editing technology hold the promise that T cell potency can be enhanced by gene modification, deletion, or addition. 1 In this issue of Molecular Therapy, Hale et al., 2 in a single construct, combine CCR5 knockdown with a chimeric antigen receptor targeting the HIV envelope, a combination strategy that can potentially provide both anti-HIV activity independent of major histocompatibility complex (MHC) expression and protection of gene-modified T cells from HIV infection.Exploitation of endogenous homologydirected recombination (HDR) pathways to introduce genetic modifications is a promising strategy to enhance T cell therapies. Harnessing HDR for gene modification involves the use of an exogenous DNA template to specify the exact outcome of DNA double-strand break repair. In other words, when a targeted DNA double-strand break is introduced, the HDR machinery can use exogenously provided single-or double-stranded DNA templates (which have sequence homology to the break site) to synthesize DNA that is used to repair the lesion, allowing for the precise insertion of gene products at the break site. 3 For example, it was shown that such a mechanism may be utilized to specifically select a region where a transgene can be expressed (limiting insertional mutagenesis events) or, more intriguingly, to simultaneously disrupt a region expressing an unwanted gene and replace it with a foreign (or favorable) genetic construct. 4